Misoprostol
Labor Onset and Length Abnormalities
University of Texas at AustinSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Labor Onset and Length Abnormalities cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Oxytocin Assiut University | Phase 4 | BB |
Same molecule, other indications
Misoprostol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →